US SB4742 | 2019-2020 | 116th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on September 29 2020 - 25% progression, died in committee
Action: 2020-09-29 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding serious or other life-threatening conditions. The bill defines routine patient costs to include items and services that would otherwise be covered under Medicaid absent the patient's participation in the clinical trial; the term includes items and services relating to trial complications, but excludes those items and services that are the subject of the trial or that are provided solely in relation to data analysis and are not otherwise covered. Additionally, a qualifying clinical trial means, among other things, a clinical trial that is approved or funded by specified entities (e.g., the National Institutes of Health) or is an authorized new drug trial.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

CLINICAL TREATMENT Act Covering Life-saving Investigations Needed In Cancer And other Life-threatening conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act

Sponsors


History

DateChamberAction
2020-09-29SenateRead twice and referred to the Committee on Finance.

Same As/Similar To

HB913 (Related) 2019-01-30 - Referred to the House Committee on Energy and Commerce.

Subjects


US Congress State Sources


Bill Comments

feedback